RE: Rick Bright talking to Peter Horby on twitter30 Jan 2023 19:17
Doc83 of course he wouldn't be that unprofessional but I remember the rancour at that time as I'm sure you do - and more importantly SNG has been right in front of Recovery ever since the P2 delivered so successfully and it's either never been submmitted for consideration (most likely in those early days when the company was determined to go it alone) or it was submitted and decided against on cost grounds.
Remembering that Recovery famously conducted the trials that gave the world Dexamthethasone. The miracle existing hospital drug that cost pennies and saved 30% of ventilated patients. The original green goddess of the Covid pandemic. Dexa results were announced almost exactly at the same time as SG016 delivered - within a few weeks, before most other drugs had even made it out of the test tube. Dexamethsone was the easiest trial ever - but for Synairgen to get from planning to completion in less than 6 months was a miracle and remains the great achievement of this company. Lord Horby of Dexa might look at SNG again but he is now following the same protease inhibitor path as STRIVE, with his latest investigation into Paxlovid - as STRIVE looks as Shioogi.
V grateful for the reposting of your and Wigster's excellent notes of the AGM. Ghia got into trouble with Td and Mani for the bottom drawer comments which of course was ridiculous. They were both spinning a narrative that we might be EUAd somehow without another trial or that a trial could be planned and completed and commercialised within a year which would never, ever have happened even if that trial had been announced on the day of the AGM.
Commercialisation is the least important part of all of this - we just need that trial and your posts remind us that they were only looking at a platform trial at that time. Hopefully NIH will have some good news for us before winter ends. The hospital patients will always be there.